Market Overview

The Global Antihypertensive Drugs Market was valued at USD 36,176.0 million in 2023 and is expected to reach USD 49,129.8 million by 2031 while growing at a CAGR of 3.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global antihypertensive drugs market growth. Antihypertensive drugs, used for treating hypertension, work by lowering blood pressure directly or addressing underlying factors. They belong to various classes, each with different mechanisms of action.

The high prevalence of hypertension and ongoing research efforts leading to the discovery of new antihypertensive drugs drive the market. However, the high cost of treatment and the preference for lifestyle modifications as first-line treatment hinder market growth.

Furthermore, the global antihypertensive drugs industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Drug Class Analysis

The Global Antihypertensive Drugs Market is segmented among Diuretics, Angiotensin-Converting Enzyme (ACE) Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, and Others, based on Drug Class. In 2023, Calcium Channel Blockers accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Distribution Channel Analysis

The Global Antihypertensive Drugs Market is segmented among Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies, based on Distribution Channel. In 2023, Hospital Pharmacy accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Antihypertensive Drugs Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), AstraZeneca plc, Lupin, Novartis AG., Johnson & Johnson, SANOFI, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Pfizer Inc., and Merck & Co., Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Antihypertensive Drugs Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Antihypertensive Drugs Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Antihypertensive Drugs Market Segmentation, By Drug Class

• Global Antihypertensive Drugs Market Share Analysis, By Drug Class

• Global Antihypertensive Drugs Market Growth Analysis, By Drug Class

• Global Antihypertensive Drugs Market Trends, By Drug Class

o Diuretics

o Angiotensin-Converting Enzyme (ACE) Inhibitors

o Calcium Channel Blockers

o Beta-adrenergic Blockers

o Vasodilators

o Others

6. Global Antihypertensive Drugs Market Segmentation, By Distribution Channel

• Global Antihypertensive Drugs Market Share Analysis, By Distribution Channel

• Global Antihypertensive Drugs Market Growth Analysis, By Distribution Channel

• Global Antihypertensive Drugs Market Trends, By Distribution Channel

o Hospital Pharmacies

o Retail Pharmacies

o Online Pharmacies

7. Global Antihypertensive Drugs Market Segmentation, By Region

• Global Antihypertensive Drugs Market Share Analysis, By Region

• Global Antihypertensive Drugs Market Growth Analysis, By Region

• Global Antihypertensive Drugs Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

• Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories) *

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• AstraZeneca plc

• Lupin

• Novartis AG.

• Johnson & Johnson

• SANOFI

• Boehringer Ingelheim International GmbH

• Daiichi Sankyo Company Limited

• Pfizer Inc.

• Merck & Co., Inc  

*Similar analysis will be provided for each company listed above.